Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1500 of 3173 entries
View as:

Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee

Phase: N/A Priority: Normal
NCT ID: NCT00137410 Org: User:
Start: 11/30/02 End: 03/31/06 Due: 03/31/07

Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01236378 Org: User:
Start: 12/31/10 End: 04/30/11 Due: 04/30/12

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Phase: N/A Priority: Normal
NCT ID: NCT01299480 Org: User:
Start: 03/03/11 End: 09/18/12 Due: 09/18/13

Nonrestorative Sleep RSQ (Restorative Sleep Questionnaire) Development-- Methodology Study

Phase: N/A Priority: Normal
NCT ID: NCT00705601 Org: User:
Start: 08/31/08 End: 01/31/09 Due: 01/31/10

Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes

Phase: N/A Priority: Normal
NCT ID: NCT01226797 Org: User:
Start: 01/17/11 End: 02/09/12 Due: 02/09/13

The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00914667 Org: User:
Start: 07/31/09 End: 08/31/09 Due: 08/31/10

A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00732992 Org: User:
Start: 08/31/08 End: 11/30/09 Due: 11/30/10

Post Market Surveillance to Observe Safety of Prevenar13™ in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01834222 Org: User:
Start: 12/31/13 End: 03/31/16 Due: 03/31/17

A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05014412 Org: User:
Start: 10/07/21 End: 05/17/25 Due: 05/17/26

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Phase: N/A Priority: Normal
NCT ID: NCT00163540 Org: User:
Start: 05/31/05 End: 06/30/05 Due: 06/30/06

Bioequivalence Study Of Verapamil

Phase: N/A Priority: Normal
NCT ID: NCT00668967 Org: User:
Start: 02/29/08 End: 07/31/08 Due: 07/31/09

A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)

Phase: N/A Priority: Normal
NCT ID: NCT05709158 Org: User:
Start: 03/01/24 End: 04/30/24 Due: 04/30/25

Study Evaluating Persistence Of Antibody Response Elicited By 13vPnC In Healthy Adults Previously Vaccinated

Phase: N/A Priority: Normal
NCT ID: NCT01025336 Org: User:
Start: 12/31/09 End: 10/31/10 Due: 10/31/11

Relative Drug Exposures Of Two Formulations of PF-02341066

Phase: N/A Priority: Normal
NCT ID: NCT00939731 Org: User:
Start: 07/31/09 End: 08/31/09 Due: 08/31/10

Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT00787319 Org: User:
Start: 01/31/10 End: 06/30/12 Due: 06/30/13

A Study Of Diflucan In Children With Ringworm Of The Scalp

Phase: N/A Priority: Normal
NCT ID: NCT00645242 Org: User:
Start: 11/30/02 End: 03/31/03 Due: 03/31/04

Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

Phase: N/A Priority: Normal
NCT ID: NCT04511533 Org: User:
Start: 08/27/20 End: 11/08/22 Due: 11/08/23

Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00634933 Org: User:
Start: 03/31/08 End: 10/31/12 Due: 10/31/13

Study Evaluating The Safety Of Xyntha In Usual Care Settings

Phase: N/A Priority: Normal
NCT ID: NCT00765726 Org: User:
Start: 02/28/09 End: 08/31/11 Due: 08/31/12

A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02066909 Org: User:
Start: 02/28/14 End: 04/30/15 Due: 04/30/16

Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679

Phase: N/A Priority: Normal
NCT ID: NCT01393652 Org: User:
Start: 05/31/11 End: 09/30/11 Due: 09/30/12

A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01004822 Org: User:
Start: 03/31/10 End: 05/31/14 Due: 05/31/15

A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05040295 Org: User:
Start: 09/10/21 End: 11/19/21 Due: 11/19/22

A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT00811499 Org: User:
Start: 12/16/08 End: 09/29/09 Due: 09/29/10

Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT01003691 Org: User:
Start: 08/05/10 End: 04/19/13 Due: 04/19/14